Home
/ Mologic
/ Competitors

Mologic Competitors and Similar CompaniesClear all

Mologic's competitors and similar companies include SNIPR Biome, Avidity Biosciences, GT Apeiron Therapeutics and Paratek Pharmaceuticals.

	Mologic In 2003, two quirky scientists vowed to make the world a better place, after learning their trades in some of the world’s biggest scientific organisations.	SNIPR Biome SNIPR Biome is a biotech company using CRISPR/Cas technology for drug development for difficult-to-treat infections.	Avidity Biosciences Avidity Biosciences is a biotech company developing oligonucleotide-based therapies called antibody oligonucleotide conjugates (AOC).	GT Apeiron Therapeutics GT Apeiron Therapeutics is a biotech company.	Paratek Pharmaceuticals Paratek Pharmaceuticals is focused on the discovery, development, and commercialization of medicines designed to save lives and alleviate suffering.
Founding Date	Founding Date 2003	Founding Date 2017	Founding Date 2013	Founding Date 2019	Founding Date 1996
Type	Type Subsidiary	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare Technology biotech drug development	Tags Healthcare Technology biotech drug development	Tags Healthcare Technology biotech drug development	Tags Healthcare Technology biotech drug development	Tags Healthcare Technology biotech drug development pharma
Locations	Locations Thurleigh, GB HQ	Locations København, DK HQ	Locations San Diego, US HQ	Locations HQ	Locations Boston, US HQ King Of Prussia, US
Employees	Employees 652% decrease	Employees 432% increase	Employees 25336% increase	Employees N/A	Employees 10123% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 5.3 b	Valuation ($) N/A	Valuation ($) 127.8 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $18.8m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $160.3m (FY, 2022)
Net income	Net income N/A	Net income N/A	Net income ($684.6m) (FY, 2025)	Net income N/A	Net income ($63.6m) (FY, 2022)
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 50m (about 7 years ago)	Latest funding round N/A	Latest funding round $ 27m (almost 7 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 8m	Total funding raised $ 50m	Total funding raised $ 131m	Total funding raised $ 27m	Total funding raised $ 93m